Global Summit
For Cancer Research and Entrepreneurship

Upcoming: Saturday, October 22, 2022


Co-Hosted by 

The Asian Fund for Cancer Research, National Foundation for Cancer Research, and AIM-HI Accelerator Fund will co-host a trio of programs celebrating cancer research success and the impact of oncology innovation. Featured Programs include New Frontiers in Cancer Research, Women’s Leadership Luncheon, and Szent-Györgyi Prize Award Ceremony.

The event will be held live in Washington, DC, USA, and also streamed online for those unable to attend in person. Attendees will include cancer research donors, cancer patients, academic and industry professionals, and other public members interested in learning about cancer research discoveries and the powerful disease-fighting products and tools.

We hope you will join us!

Why Should You Attend This Event?

  • Be inspired by world-renowned speakers on the latest landscape change of translational cancer research
  • Actively engage in thought-provoking discussions with key opinion leaders
  • Personally interact with award-winning pioneer scientists and join the celebration of their breakthrough cancer discoveries

Program Agenda

Part I: New Frontiers for Cancer Research

8:45 am -12:30 pm

8:45-8:55 am:

Master of Ceremony:  Mr. Lance Kawaguchi, Board Member of NFCR, Chairman of AFCR

Welcome and Opening Remarks:  Dr. Sujuan Ba, Founder & CEO of AFCR, CEO of NFCR, Co-Founder of AIM-HI

8:55-9:15 am:

 Keynote Speech:  TBD

Session I: Molecular approaches to understand and treat cancer

9:15-10:45 am:

Moderator:  Dr. Web Cavenee, USCD and Ludwig Institute for Cancer Research

Panel Members:

Dr. Ken Anderson, Professor of Medicine, Harvard; Physician Oncology, Brigham and Women’s Hospital

Dr. Teresa Davoli, Assistant Professor, Cancer Genetics and Genomics, New York University

Dr. Aaron N. Hata, Assistant Professor of Medicine; Harvard Medical School

Dr. Jeremiah Johnson, Professor of Chemistry; Massachusetts Institute of Technology

Dr. Suzanne Topalian, Professor of Oncology and Surgery, Johns Hopkins University

Dr. Katherine Uyhazi, Assistant Professor of Ophthalmology, University of Pennsylvania 

10:45-11:00 am Coffee Break

Session II: New Approaches to Treat Breast, Pancreatic and Head and Neck Cancer

11:00 am-12:30 pm:

Moderator:  Dr. Jennifer Grandis, University of California, San Francisco

Panel Members: 

Dr. Lisa Coussens, Professor and Chair, Department of Cell, Developmental & Cancer Biology, Oregon Health and Sciences University

Dr. Daniel Haber, Director, Massachusetts General Hospital Cancer Center

Dr. Courtney Houchen, Professor, Chief of Digestive Diseases and Nutrition, Oklahoma University School of Medicine

Dr. Daniel Johnson, Professor and Vice Chair of Research, Otolaryngology and Head and Neck Surgery, University of California, San Francisco

Dr. Kornelia Polyak, Professor of Medicine, Dana-Farber Cancer Institute, Harvard

Dr. Xiang-Lei Yang, Professor of Molecular Biology and Medicine, Scripps Research

Closing Remarks: Mr. Lance Kawaguchi

Part II: AIM-HI Women’s Venture Competition Luncheon & Award Ceremony

12:45-2:15 pm

12:45-2:15 pm:

Master of Ceremony: Rose Wang, Executive Advisor of AIM-HI

Opening Remarks: Dr. Sujuan Ba, CEO & Co-Founder, AIM-HI


Award presenting speech to introduce the 3 Finalists of the 2022 AIM-HI Women’s Venture Competition: 

  • Drs. Pam Garzone & Raju Kucherlapati, Co-Chairs of the Competition Selection & Judging Committees
  • Presenting the Awards to the Top 3 Finalists:
    • Johanna Webb, President, RiverWalk Therapeutics
    • Revital Mandil-Levin, CEO & Co-Founder, Nanocarry Therapeutics
    • Rosa Hwang, Co-Founder, Stellanova Therapeutics


Award presenting speech to introduce the 2022 AIM-HI Women’s Beacon Award for Leadership in Oncology

  • Award Speech, winner of the 2022 AIM-HI Women’s Beacon Award for Leadership in Oncology


Closing Remarks: Dr. Sujuan Ba

Part III: AIM-HI Portfolio Companies Showcase

2:30-4:00 pm

2:30-4:00 pm:

Welcome and Opening Remarks:  Dr. Sujuan Ba, CEO of NFCR, Co-Founder of AIM-HI & Founder of AFCR

Presentation: Dr. Lou Lieto, Partner, Patents and Innovations, Wilson Sonsini Goodrich & Rosati

  • Critical Intellectual Property Protection Strategies & Common Pitfalls for Early-stage Companies

Panel Discussion: Opportunities & Challenges Facing Leadership of Early-stage Oncology Companies

Moderator:  John Stanford, Executive Director, Incubate


  • Manijeh Goldberg, CEO, Privo Technologies
  • Vlad Hogenhuis, CEO, Chimera Bioengineering
  • Pritesh Gandhi, CEO, TellBio
  • Ken Malone, CEO, Rasio Therapeutics
  • John Luk, CEO of Arbele Bio


Closing Remarks:  Dr. Alfred Slanetz, Chairman of the NFCR

Part IV: 2022 Szent-Györgyi Prize Dinner & Award Ceremony – Black-Tie Optional

6:00-7:00 pm Cocktail Reception / 7:00-8:30 pm Dinner & Award Ceremony

6:00-7:00 pm:

Cocktail Reception

7:00-8:30 pm:

Dinner & Award Ceremony

Master of Ceremony: Mr. Lance Kawaguchi, Board Member of NFCR, Chairman of AFCR & CEO of CBCF

Moment of Silence


Welcome and Opening Remarks: Dr. Sujuan Ba, CEO of NFCR and Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

Keynote Presentation: (Underwriting Sponsor)

Introduction of the 2022 Szent-Györgyi Prize Winner and Award Trophy Presentation: 

Dr. Mark M. Davis, Stanford School of Medicine, and Dr. Tak Mak, University of Toronto and Prince Margaret Cancer Centre, Co-Chairs of the 2022 Selection Committee for the Szent-Györgyi Prize

2022 Szent-Györgyi Prize Winner Award Speech To Be Announced

Cancer Research and Cancer Survivor:  Katie Banovich and Greyson  


Acknowledgements & Closing Remarks:  Lance Kawaguchi

Sponsorship Opportunities

Inquiries regarding event sponsorship can be made by e-mail at